Next Article in Journal
Simultaneous Analysis of Nicarbazin, Diclazuril, Toltrazuril, and Its Two Metabolites in Chicken Muscle and Eggs by In-Syringe Dispersive Solid-Phase Filter Clean-Up Followed by Liquid Chromatography–Tandem Mass Spectrometry
Previous Article in Journal
Updated Parameters for Listeria monocytogenes Dose–Response Model Considering Pathogen Virulence and Age and Sex of Consumer
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Reuterin, Phenyllactic Acid, and Exopolysaccharides as Main Antifungal Molecules Produced by Lactic Acid Bacteria: A Scoping Review

by
Andrea Ponzio
1,*,
Annalisa Rebecchi
1,
Rosanna Zivoli
2 and
Lorenzo Morelli
1
1
Department for Sustainable Food Process, Faculty of Agriculture, Food and Environmental Sciences, Università Cattolica del Sacro Cuore, 29122 Piacenza, Italy
2
Soremartec Italia S.r.l. (Ferrero Group), P.le P. Ferrero 1, 12051 Alba, Italy
*
Author to whom correspondence should be addressed.
Foods 2024, 13(5), 752; https://doi.org/10.3390/foods13050752
Submission received: 2 February 2024 / Revised: 23 February 2024 / Accepted: 27 February 2024 / Published: 29 February 2024
(This article belongs to the Section Food Microbiology)

Abstract

:
The primary goal of this scoping review is to collect, analyze, and critically describe information regarding the role of the main compounds (reuterin, phenyllactic acid, and exopolysaccharides) produced by LAB that possess antifungal properties and provide some suggestions for further research. The use of lactic acid bacteria (LAB) to mitigate spoilage and extend the shelf life of foodstuffs has a long history. Recently, there has been a growing interest in the unique properties of these additions to the foodstuffs in which they are applied. In recent studies regarding biopreservation, significant attention has been given to the role of these microorganisms and their metabolites. This fascinating recent discipline aims not only to replace traditional preservation systems, but also to improve the overall quality of the final product. The biologically active by-products produced by lactic acid bacteria are synthesized under certain conditions (time, temperature, aerobiosis, acidity, water activity, etc.), which can be enacted through one of the oldest approaches to food processing: fermentation (commonly used in the dairy and bakery sectors). This study also delves into the biosynthetic pathways through which they are synthesized, with a particular emphasis on what is known about the mechanisms of action against molds in relation to the type of food.

Graphical Abstract

1. Introduction

This scoping review deals with a critical analysis regarding a very topical subject of previous research on antifungal activity (highlighting gaps, incompleteness, and errors) and suggestions are made as to the most promising aspects that should be further investigated.
Biopreservation is an interesting topic because there is a growing desire to ensure freshness and safety until the expiry date, reducing food waste; this challenge is linked to economic and sustainability issues. Food loss is not a problem that concerns food products in the strict sense; in fact, it has repercussions along the entire supply chain: from the farm, where the defect (or damage) of the product makes it unusable and, therefore, there has been a waste of water, energy, and other resources, to the last steps before sale, such as proper storage or transport without the waste of packaging, fuel, or energy of various kinds [1].
Related to the concept of food losses and waste is that of food spoilage, i.e., a visual, olfactory, and/or organoleptic change that makes it impossible to consume a food product. The cause can be found in micro-organisms of different types (such as bacteria, molds, and fungi or yeasts), or in larger living organisms such as insects or small animals; in any case, their presence is due to the ideal mix of food source and optimal environmental conditions for their growth [2,3]. In particular, fungi spoilage is responsible for significant food waste and economic losses; worldwide, microbial contamination caused by fungi and toxins is believed to cause problems for about 25% of products in the food sector [4].
Lactic acid bacteria (LAB) are Gram-positive, catalase-negative, non-spore-forming, facultative anaerobic microorganisms used in various food industries (bakery, dairy, fermented meats, vegetables, etc.) [5]. And it is precisely this characteristic versatility that makes them important in the food sector; each of the different LAB species has a greater or lesser potential depending on the application precisely because, depending on the conditions (nutrient sources and environmental conditions), the aforementioned compounds can be synthesized and improve the food in different aspects. Therefore, the interesting variety of metabolites they synthesized during fermentation makes them a promising addition to food; the use of such compounds to reduce the levels of or completely replace antifungal chemical preservatives is the most interesting and current alternative, as these microorganisms are generally recognized as safe (GRAS) [6,7]. It is intriguing how this recent interest goes hand in hand with a very ancient technique: fermentation. In fermentation, microorganisms improve the product’s taste, texture, organoleptic and nutritional values, shelf-life, and safety [8,9].
Biopreservatives with antifungal action are compounds produced by many species, including animals and plants, but this study covers only the ones produced by LAB: organic acids (lactic acid, acetic acid, fatty acids, phenyllactic acid, etc.), reuterin, exopolysaccharides, volatile compounds (for instance, diacetyl), antifungal peptides, hydrogen peroxide (H2O2), nucleosides, and cyclic dipeptides [10]. In particular, this scoping review focuses on three of the main metabolites: reuterin (Reu), phenyllactic acid (PLA), and exopolysaccharides (EPSs) [11]. The decision to deal with this topic was the result of a thorough literature search (taken from various scientific databases) of the last two decades concerning these metabolites and their possible usefulness in the agro-food world; in order to have a clear overview, some keywords were used for this screening of scientific literature: “BioPreservation”; “Lactic Acid Bacteria”; “Fermentation”; “Food”; “Food Spoilage”; “Antifungal Metabolites”; “Phenyllactic Acid”; “Reuterin”; and “Exopolysaccharides”. The specific choice of these three compounds is the result of an overall assessment of the substances produced as a result of fermentation. They have been chosen because they are the most interesting, promising, and discussed in the last period; because they mainly concern applications in two very relevant food sectors: dairy and baking; and, above all, because the information on them is not yet fully comprehensive. Section 2, Section 3 and Section 4 will analyze the biosynthetic processes, the antifungal effect and mechanism, and the most interesting published studies with their applications.

2. Reuterin

Reuterin (Reu) is a broad-spectrum, non-protein, antimicrobial substance whose effect, initially observed only at the antimicrobial level, was observed in the 1980s by Axelsson et al. [12,13]. This initial application of reuterin demonstrated higher effectiveness against Gram-negative microorganisms (Escherichia coli and Salmonella enterica), which are more sensitive compared to Gram-positive microorganisms (Listeria monocytogenes and Staphylococcus aureus); only later was its potential as an antifungal agent observed [14,15]. Reu, a bacteriocin named after the manufacturer Limosilactobacillus reuteri (the recent new nomenclature registered in the International Journal of Systematic and Evolutionary Microbiology), is not the only species that produces reuterin [16]; in fact, the potential to produce this low-molecular-weight compound can be found in some intestinal bacteria such as E. hallii, Ruminococcus obeum, E. coli, Ruminococcus gnavus, Flavonifractor prautii, Intestinimonas butyriciproducens, and Veillonella spp. [17]. However, it should be noted that these microorganisms are not optimal for reuterin synthesis [18,19].
Many studies have been published on reuterin due to its important biopreservative capabilities. However, some of them contain some misleading information (and this confusion also supports the need for a scoping study such as this one). For example, reuterin has been mistakenly attributed with the Qualified Presumption of Safety status (QPS) in the European Union, but this title should be used to qualify bacterial microorganisms, not metabolites [20].
Today, the term “reuterin” is used to refer to a multi-compound system in which 3-hydroxypropionaldehyde (3-HPA) (primary fraction for what concerns antimicrobial activity), 3-HPA hydrate, 3-HPA dimer, and acrolein are found [17]; the latter component has been indicated as the major contributor to the antimicrobial activity attributed to reuterin [18]. It is known that acrolein has been classified as a class 2A carcinogen by the World Health Organization; therefore, the use of reuterin in food is a cause for concern because of the repercussions on human health [21]. It must always be borne in mind that humans can come into contact with this compound in various situations, as acrolein can be found in what we ingest (food, drink, and even tobacco smoke) or our environment [22].
Glycerol (C3H8O3), a key compound in the process of reuterin synthesis, which is ubiquitous in nature, is essential for the process to begin [23]. Several microorganisms can exploit glycerol as a carbon source [24], which can be utilized through an oxidative or reductive pathway [25]. These series of reactions are made possible by specific genes: those of the 1,2-propanediol utilization operon (pdu) (Figure 1). In some Salmonella and Lactobacillus species, it is possible to trace this particular operon [26,27], and it consists of:
  • 1,2-propanediol dehydratase;
  • Genes related to vitamin B12 reactivase and regeneration activities;
  • CoA-dependent propionaldehyde dehydrogenase (pduP);
  • Additional enzyme activities [25].
Figure 1. The pdu operon metabolic pathway of reuterin and its system.
Figure 1. The pdu operon metabolic pathway of reuterin and its system.
Foods 13 00752 g001
When converting glycerol to reuterin, it is not sufficient to focus on and analyze only the pdu operon genes; another cluster responsible for vitamin B12 (pdu-cbi-cob-hem) production is essential. In this case, when clusters of genes are considered, the term “gene island” is used to describe the two closely located clusters [28].
The pdu operon genes are not the only genes that make the conversion of glycerol to 3-HP via the 3-HPA intermediate possible; in fact, a second possibility lies in the dha operon genes (Figure 2). Unlike the one described above, 3-Hydroxypropionaldehyde (3-HP) is obtained through a reaction that occurs in two steps: first, glycerol is converted to 3-Hydroxypropionaldehyde (3-HPA) by a dehydratase; at a later stage, 3-HP is obtained from a reaction catalyzed by a dehydrogenase. The genes that constitute the dha operon fundamentally encode a:
  • Glycerol dehydratase (dhaB);
  • Glycerol dehydratase reactivase (gdr);
  • 1,3-propanediol oxidoreductase (dhaT) [29].
Figure 2. The dha operon metabolic pathway of reuterin.
Figure 2. The dha operon metabolic pathway of reuterin.
Foods 13 00752 g002
The bacteria that possess such characteristic enzymes are those belonging to the genera of Enterobacteriaceae, such as some Klebsiella; in addition, it is possible to find them in different gene constructions in other microorganisms, such as some Lactobacillus or Clostridium [25].
Further work is needed for a better understanding of the mechanism of action of reuterin against bacteria and fungi. Some antimicrobial mechanisms have been analyzed for some components of the reuterin system, such as 3-HPA dimer, 3-HPA (reuterin), or acrolein. In fact, 3-HPA dimer, through competitive inhibition, affects DNA synthesis, blocking the action of ribonucleotide reductase. 3-HPA causes oxidative damage at the protein level by reducing sulfhydryl groups; this is believed to be possible due to the aldehyde groups of reuterin. Acrolein, however, exploiting a Michael addition reaction, also achieves the antimicrobial oxidative result of 3-HPA; in this case, synergistic cooperation with 3-HP has been noted. Although the short-term toxicity tests using in vitro models of the gastrointestinal tract have shown reassuring results [15], further, more complex studies are needed.
In recent decades, several studies have been conducted to obtain naturally preserved food products to meet the increasing consumer demand. Initially, the inhibitory action against bacteria was evaluated. One example is the publication by E. Røssland et al., in which it was noted that, in fermented milk, bacteriocins have no effect on Bacillus cereus and, if the pH is not reduced rapidly in the initial phase of the fermentation log, management becomes problematic, as it has the potential to sporulate and exist as endospores [30]. In addition, the article by J.L. Arqués et al. addresses the relationship between reuterin and other LAB-bacteriocins in preventing the growth of foodborne pathogens in milk. The study found that reuterin had a bacteriostatic effect on Listeria monocytogenes at the tested temperatures [31].
Furthermore, it has been evaluated and evidence has been provided that the combination production and antifungal activity of reuterin, synthesized by lactic acid bacteria, has a positive effect on silage [32].
Important for applications in food processing is the recently made discovery about reuterin: An LAB strain was found to produce it even under aerobic conditions at low temperatures. In dairy applications, the handling of reuterin has to be carefully controlled so that its strong antifungal power does not affect the cheese-making process when the use of mold is involved in the production [33].
A few studies on the effect of bacteriocins have been conducted, but the behavior of reuterin in food matrices needs further investigation. Recently, the antimicrobial action in fermented milk was evaluated: bacterial and fungal (Penicillium expanusm) microbial growth was inactivated [34]. In the wake of fermented dairy products, the effect of reuterin in yogurt was analyzed in 2019, observing a reduction in fungal development (at lower concentrations) and a fungicidal effect (at higher concentrations) [35]. Regarding the actual functioning of the antifungal mechanism of reuterin, theories have been developed: a modification of small molecules and thiol stress groups causes oxidative stress to molds and fungi [36]; a more recent (in silico) study came to the conclusion that the mechanism acts at the enzyme level, inhibiting catalase, catalase-peroxidase, and spore-specific catalase (of A. flavus). In particular, reuterin would cause an accumulation of ROS in the cells as a result of competition due to a binding between reuterin and enzyme active sites [37].
Different studies have evaluated the antifungal activity of Reu in vitro at different concentrations, and the results have shown that the minimal inhibitory concentrations (MIC) ranged from 1.89 mM to 7.58 mM and from 4 to 10 mmol/L [38,39].
Reuterin appears to be a promising alternative to chemical additives, especially in the dairy industry, but further studies and evaluations are needed. In particular, it would be beneficial for future research to focus on gaining a deeper understanding of the process by which fungi are inhibited and evaluating the effectiveness of reuterin as an antimicrobial agent when applied to complex food matrices. As already mentioned, one aspect that still raises questions concerns acrolein (or 2-propenal) and the possible occurrence of certain diseases as a result of interaction with the human organism. So far, research that has dealt with the evaluation of cytotoxicity in the reuterine system has not shown any worrying results [15], but the question still exists, and it is urgent to find a reassuring definitive answer because, to date, there are no studies in the existing literature that deal with this danger in the long term.
In conclusion, it would be interesting to evaluate whether, in addition to dairy products, reuterin seems to be the option with the greatest prospects in other food categories; an exciting application to investigate is in plant-based food.

3. Phenyllactic Acid

An additional substance whose functions include inhibiting bacterial and fungal development is phenyllactic acid (PLA). Among the metabolites produced by lactic acid bacteria, PLA is one of the cornerstones of antifungal activity. It has been noted that, under high acidity conditions and concentration levels, PLA performs better against fungal growth than lactic acid and acetic acid [40,41].
PLA, or 2-hydroxy-3-phenyl propionic acid (C9H10O3), is a natural organic acid resulting from the metabolism of phenylalanine (Phe) [42]. At the microbial level, the synthesis of this important broad-spectrum antimicrobial compound was first examined in 1998 in Geotrichum candidum against the growth of L. monocytogens [43]. PLA biosynthesis has also been observed, at a later stage, in microorganisms other than LAB, such as exploited E. coli; in fact, such biosynthesis is made possible by a specific gene (D-lactate dehydrogenase), the lack of which makes PLA production impossible [44,45].
Luo et al. reported that the D-PLA isoform is more intriguing than the L-PLA isoform due to its potential as an antimicrobial and antiseptic agent, thermal stability, effectiveness, dynamic behavior within a wide pH range, and solubility in water. These properties apply to the food, feed, and pharmaceutical fields [46]. Over the years, several studies have been conducted (especially in leavened bakery products) on this compound, whose presence in fermented food products is not uncommon [10]. In fact, research has shown that an inhibiting action against Penicillium expansum, P. verrucosum, P. citrinum, P. roqueforti, Aspergillus flavus, A. ochraceus A. niger, Monilia sitophila, Fusarium graminearum, Candida pulcherrima, etc., occurs [47].
However, the antifungal efficacy of PLA is still a matter of debate: the amount present in some natural foods would appear to be insufficient for bio-preservation purposes [48]. Even with regard to minimal inhibitory concentration (MIC) values, further studies will be necessary, as more, or less, interesting values (3–300 mM) can be obtained depending on the matrix and the level of environmental acidity [49]. For example, it has been noted that PLA is characterized by an MIC value that varies depending on the microorganism it is tested against: for Aspergillus fumigatus, it is 2.5 mg/mL; in contrast, against Aspergillus niger, the value is 20 mg/mL [50,51].
Main LAB species producing PLA include Lactiplantibacillus plantarum, Companilactobacillus crustorum, Lentilactobacillus buchneri, Limosilactobacillus reuteri, Levilactobacillus brevis, Lacticaseibacillus casei, Lactobacillus delbrueckii, Pediococcus acidilactici, and Weissella confusa [52,53]. To analyze the process of PLA synthesis by LAB, three pathways have been identified through a multi-omics analysis (Figure 3):
  • Core pathway—the one that has been most studied;
  • De novo biosynthetic pathway or central carbon metabolism;
  • Auxiliary pathway [49].
Figure 3. The three biosynthetic pathways of phenyllactic acid.
Figure 3. The three biosynthetic pathways of phenyllactic acid.
Foods 13 00752 g003
Again, there is not much information regarding how the antifungal mechanism works. At present, it is believed that, because of an interaction with the proton gradient, phenyllactic acid (with the help of other metabolites) may have an inhibitory effect at the level of cellular enzymes [11].
PLA is still a metabolite under discussion regarding its potential as a bioconservative; some of the existing literature ranks it among the most interesting organic acids in spoilage inhibition [54,55], and others claim that its contribution is irrelevant to mold development [56]. Several studies have investigated this metabolite, and compared to other compounds, more data can be found on food as a complex matrix. In a recent study, through the addition of PLA, an inhibiting effect against Penicillium paneum and Aspergillus niger was observed in bread production [41]. The limiting aspects of this substance for preservative purposes are bacterial production inefficiency and a high cost at the producer level [57]. Although it is a much-treasured metabolite, theories and models have been elaborated as to the mechanism by which PLA inhibits fungal growth: suppression of the sporulation phase and radial growth [49].
Therefore, future studies should investigate the production (identifying optimal conditions), mechanism of action, and stability of this substance against molds while continuing to work on processes and/or finished products to obtain more representative results. In contrast to other promising substances in the field of biopreservation, a safety assessment of PLA has been carried out, finding this metabolite to be non-toxic (and not to cause olfactory level changes) for animals and humans [58].
Given the growing interest, this should be applied not only to traditional doughs and bakery products, but also to sourdoughs generated from different raw materials; the highlight of this compound is its stability during baking [59].
Therefore, the future objective is to verify the actual antifungal potential and the sensory and organoleptic evaluation of the final product. The importance of determining the minimum inhibitory concentration of PLA for the main type of fungi in relation to the specific product it is used on should not be overlooked.

4. Exopolysaccharides

Related to biopreservation, there has been a recent increase in interest in another class of compounds of microbial origin: exopolysaccharides (EPSs), which are secondary metabolites produced mainly during bacterial growth [60]. The name “exopolysaccharide” was designated in 1967 to refer to high-molecular-weight (HMW) carbohydrates secreted into the environment by microorganisms. EPSs are considered extracellular polymers, as 40–95% of extracellular polymers include polysaccharides [61].
This scoping study focuses on microbial-derived EPSs, particularly those produced by lactic acid bacteria. LAB can synthesize and release these degradable biopolymers, whose basic units are sugar monosaccharides, into the extracellular environment under certain conditions [62]. Exopolysaccharide biosynthesis is influenced by the presence or absence of carbon and nitrogen sources, acidity, temperature, oxygen availability, and cellular concentration [63].
Exploiting EPS’s technological and functional properties is a promising tool in industrial food application. These long-chain polysaccharides lend themselves as structural modifiers due to their water-holding capacity; moreover, given their beneficial effect, they are also a prebiotic, anti-inflammatory, anti-cancer, antioxidant, and antiviral alternative [64]. An additional and interesting application is to exploit these compounds to form films for biodegradable packaging [65].
Recently, there has been increased interest in the use of metal nanoparticles in response to drug resistance by pathogens. Recent research has assessed this possibility, given the potential of these innovative alternatives due to their environmentally friendly synthesis and broad spectrum of action against various microorganisms. This topic is related to exopolysaccharides as an excellent substrate for the synthesis of the nanoparticles tested, and they have been shown to have good antimicrobial activity against Gram-positive and Gram-negative bacteria as well as fungi [66].
However, the main reason they are discussed in this review is their potential application for antifungal purposes, but it would be of significant interest to study and correlate the presence of these metabolites with advantages and benefits on final products. Taking chemical structure as a reference, exopolysaccharides can be divided into two classes (Figure 4): homopolysaccharides (HoPSs) and heteropolysaccharides (HePSs) [67]. This classification is based on the composition of the sugar unit: in HoPSs, the residual sugar present is of a single type; in contrast, HePSs are polymers formed from different types of monosaccharides [68,69].
As for HoPSs, there are four groups into which they can be subdivided according to the position and type of bonding of the carbon involved:
  • α-glucans, in which dextran (α-1,6), alternans (1,3 α and α-1,6), mutans (1,3 α and α-1,6), and reuterans (1,4 and α-1,6) can be distinguished;
  • β-glucans, only one type linked via β-1,2, β-1,3, and β-1,4 glycosidic bonds;
  • β-fructans, formed by the subgroups of inulin-type (β-2,1) and levan (β-2,6);
  • Galactans: bonds that characterize this rarer class produced by Lactobacillus spp. are β-1,3 or β-1,6 [70,71].
Microorganisms capable of producing this type of polymer include Limosilactobacillus fermentum, Lactobacillus johnsonii, and Leuconostoc mesenteroides [72].
Turning to HePSs, most LAB-EPSs (lactic acid bacteria-derived exopolysaccharides) fall into this group. Usually, these are chains composed of three to eight units of sugars, such as glucose, galactose, or rhamnose. The three sugars just mentioned are not the only ones present; other monosaccharides such as fructose, mannose, fucose, glucuronic acid, and N-acetyl-glucosides can be found [73].
It has been noted that there are several bacteria capable of producing such exopolysaccharides; among them are Lactococcus lactis, Lactobacillus rhamnosus, Lacticasei-bacillus casei, Lactobacillus delbrueckii, Lactobacillus bulgaricus, Lactobacillus acidophilus, Lactobacillus helveticus, and Streptococcus [74].
Moreover, another issue involving exopolysaccharides is complex, partly because of the large number of gene products involved in biosynthesis [75]. To date, four pathways for the synthesis of LAB-EPSs have been identified: the extracellular synthesis pathway, the synthase-dependent pathway, the ATP-Binding Cassette (ABC) transporter-dependent pathway, and the Wzx/Wzy-dependent pathway. Of those mentioned, the two most exploited pathways are the extracellular synthesis (Figure 5) and the Wzx/Wzy-dependent synthesis pathways [71,76].
The Wzx/Wzy-dependent pathway of HePSs is a complex process consisting of five steps (Figure 6). It is a complicated mechanism that differs according to the starting sugar: mannose, fructose, glucose, or lactose [76,77].
In addition to the synthase-dependent pathway and the Wzx/Wzy-dependent pathway, there is a third intracellular pathway: the ATP-Binding Cassette (ABC) transporter-dependent pathway. This relates more to capsular polysaccharides (CPSs), and being anchored to the cell surface, they are not considered true exopolysaccharides [78].
In the work of Wu et al., three possible points where EPSs show inhibitory effects against fungi were identified: destruction of cell and plasma membrane, altering cell division, or degrading DNA, whereas in 2018, in the publication by Abinaya et al., it was noted that, depending on the permeability of the cell membrane, EPSs can affect the respiratory chain, causing fungal cell death [79].
Linked to membrane permeability, polysaccharides’ possibility of barrier action to inhibit the development of fungi and bacteria was investigated. As the concentration of EPS increases, the incoming amount of nutrients and substances essential for pathogen survival should decrease [80].
An additional target of EPS has been identified against biofilms. Polysaccharides can reduce the possibility of fungal adhesion, hydrophobicity (destabilizing the structure), mobility, and cellular interactions for biofilm production [60,79]. Recently, the activity against biofilms by EPSs was investigated in depth by Wang et al., and it was found that these metabolites synthesized by LAB are capable of modifying bacteria and fungi at the cellular level, suppressing the anchoring activity of pathogens, and also affecting this process at the gene level [81,82].
EPS synthesized from certain Lactobacillus strains show intriguing potential in the fungal inhibition of certain Candida species [83,84]; the presence of lactic acid bacteria and the substances they produce is able to provide protection to oral epithelial cells by preventing fungal adhesion [85].
The minimum inhibitory concentration (MIC) of EPS was evaluated in a recent study, in which (after purification) different concentrations were tested against different microorganisms (P. aeruginosa, E. coli, S. aureus, B. subtilis, C. albicans, and A. niger). This resulted in an MIC value between 15 µg/mL and 52 µg/mL, depending on the bacterium or mold [86].
Exopolysaccharides are best known for the properties they can impart to the products in which they are applied, especially at the structural level. The most promising sectors for their application for biopreservative purposes are bakery and dairy, but knowledge of the mechanism in its entirety is still limited. Likewise, work on the application in bakery products would require more in-depth investigation, especially due to the thermostability (given the treatment to which such foods are usually subjected). One of the most recent and interesting works on biopreservation in a bakery was published by Illueca, Francisco, et al. in 2023; in the article, the antifungal power of LAB applied to sourdough is evaluated, and the topic is explored from different aspects [87].
An article such as the one just mentioned should be taken as an example, as there are not many that channel and relate, within the same work, the different facets, such as LAB-substrate interaction, the fermentation process with its metabolomic analysis, the thermostability of the synthesised compounds and the inhibitory power of the most representative fungi.
An interesting peculiarity of future work could be to perform a complete screening of the exopolysaccharides in a given food matrix and subsequently understand whether there are compounds that have more or less relevance at the antifungal level.

5. Conclusions

The challenge in the agri-food chain is always the same: to meet consumer demand. Today, the consumer pays more attention to the product when purchasing, preferring clean labels; zero-kilometer, organic products; or brands committed to combating food waste. Following this trend, the term “sustainability” is currently being abused and applied to different areas. Although it is a hot topic as a global need, in the food sector, economic assessments must also be made in parallel to see whether it makes sense to bear the costs for that type of production.
One of the most appealing possibilities for improvement in the food sector is biopreservation, i.e., the development and implementation of natural processes such as fermentation and the related use of microorganisms, in order to achieve a reduction in the use of chemical preservatives without affecting shelf-life too much, but also improvements in terms of technology, organoleptic properties, and safety. The microorganisms most commonly used for these applications include lactic acid bacteria, and the changes that can be achieved in the product are due to the variety of substances synthesized during the fermentation process: organic acids, acids derived from amino acids, reuterin system, cyclic dipeptides, fatty acids, and volatile compounds. Depending on the starting matrix, not only are each of these substances produced in different quantities, but the effect on the food can also differ. This adaptability makes LAB even more advantageous in the agri-food sector. The microorganisms most commonly used for these applications belong to the lactic acid bacteria category, and the changes in the product are due to the very compounds they can synthesize and release during fermentation.
The aspect that arouses so much interest in this area of research is the promising inhibitory effect these substances can have on bacteria and fungi. Important progress has been made in recent years; however, further studies are needed to fully understand how these metabolites work (Figure 7). In particular, the future challenge concerning these compounds is to discover every single step of the mechanism by which fungal development is inhibited. Once this automatism is understood, it will finally be possible to improve research efficiency by applying the best compound to the relative food for which it performs best.
To date, two of the aspects that need to be better known concern the verification of the possible repercussions (positive and negative) on the human organism following prolonged ingestion of these substances; but as already mentioned, it is no less important to know the entire process of action of molecules with antifungal power in order to be able to exploit it to its full potential.
Once a good understanding of the behavior of these substances is obtained, applications in the food system can be diverse, e.g., by incorporating them into packaging technologies. The importance of fermentation for biopreservation is fundamental; this technique, once understood and exploited to its full potential, will provide the solution to two of the main challenges facing the agri-food sector today: the reduction in chemical preservatives by not excessively altering shelf life and the reduction in food waste due to fungal spoilage.
In conclusion, reviews that delve into and critically examine (highlighting gaps and inaccuracies) an emerging topic such as this are increasingly useful in bringing together the fragmented information in the literature and are an asset in understanding where to direct and optimize the focus of future research.

Author Contributions

Conceptualization, A.P., A.R. and L.M.; methodology, A.P. and L.M.; validation, L.M.; investigation, A.P., A.R. and L.M.; writing—original draft preparation, A.P., A.R. and L.M.; writing—review and editing, L.M., A.R. and R.Z.; visualization, L.M.; supervision, A.R. and L.M.; project administration, A.P. and L.M. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The original contributions presented in the study are included in the article, further inquiries can be directed to the corresponding author.

Conflicts of Interest

Author Rosanna Zivoli was employed by the company SOREMARTEC ITALIA SRL., which had the role of writing—review and editing in this study. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

  1. Vågsholm, I.; Arzoomand, N.S.; Boqvist, S. Food Security, Safety, and Sustainability—Getting the Trade-Offs Right. Front. Sustain. Food Syst. 2020, 4, 16. [Google Scholar] [CrossRef]
  2. Nychas, G.E.; Panagou, E. Microbiological spoilage of foods and beverages. In Food and Beverage Stability and Shelf Life; Woodhead Publishing: Sawston, UK, 2011; pp. 3–28. [Google Scholar]
  3. Vesković-Moračanin, S.; Milijašević, M.; Borović, B.; Kureljušić, J. Food Loss and Waste: A Global Problem. Meat Technol. 2023, 64, 293–297. [Google Scholar] [CrossRef]
  4. Sellamani, M.; Kalagatur, N.K.; Siddaiah, C.; Mudili, V.; Krishna, K.; Natarajan, G.; Putcha, V.L.R. Antifungal and Zearalenone Inhibitory Activity of Pediococcus pentosaceus Isolated from Dairy Products on Fusarium graminearum. Front. Microbiol. 2016, 7, 890. [Google Scholar] [CrossRef] [PubMed]
  5. García, C.; Rendueles, M.; Díaz, M. Liquid-phase food fermentations with microbial consortia involving lactic acid bacteria: A review. Food Res. Int. 2019, 119, 207–220. [Google Scholar] [CrossRef] [PubMed]
  6. Kaveh, S.; Hashemi, S.M.B.; Abedi, E.; Amiri, M.J.; Conte, F.L. Bio-Preservation of Meat and Fermented Meat Products by Lactic Acid Bacteria Strains and Their Antibacterial Metabolites. Sustainability 2023, 15, 10154. [Google Scholar] [CrossRef]
  7. Leyva Salas, M.; Mounier, J.; Valence, F.; Coton, M.; Thierry, A.; Coton, E. Antifungal Microbial Agents for Food Biopreservation—A Review. Microorganisms 2017, 5, 37. [Google Scholar] [CrossRef] [PubMed]
  8. Khalil, N.; Dabour, N.; Kheadr, E. Food Bio-Preservation: An Overview with Particular Attention to Lactobacillus plantarum. Alex. J. Food Sci. Technol. 2021, 18, 33–50. [Google Scholar] [CrossRef]
  9. Fischer, S.W.; Titgemeyer, F. Protective Cultures in Food Products: From Science to Market. Foods 2023, 12, 1541. [Google Scholar] [CrossRef]
  10. Bourdichon, F.; Arias, E.; Babuchowski, A.; Bückle, A.; Bello, F.D.; Dubois, A.; Fontana, A.; Fritz, D.; Kemperman, R.; Laulund, S.; et al. The forgotten role of food cultures. FEMS Microbiol. Lett. 2021, 368, fnab085. [Google Scholar] [CrossRef]
  11. Mishra, B.; Mishra, A.K.; Kumar, S.; Mandal, S.K.; Nsv, L.; Kumar, V.; Baek, K.-H.; Mohanta, Y.K. Antifungal Metabolites as Food Bio-Preservative: Innovation, Outlook, and Challenges. Metabolites 2021, 12, 12. [Google Scholar] [CrossRef]
  12. Axelsson, L.T.; Chung, T.C.; Dobrogosz, W.J.; Lindgren, S.E. Production of a Broad Spectrum Antimicrobial Substance by Lactobacillus reuteri. Microb. Ecol. Health Dis. 1989, 2, 131–136. [Google Scholar] [CrossRef]
  13. Liang, N.; Neužil-Bunešová, V.; Tejnecký, V.; Gänzle, M.; Schwab, C. 3-Hydroxypropionic acid contributes to the antibacterial activity of glycerol metabolism by the food microbe Limosilactobacillus reuteri. Food Microbiol. 2021, 98, 103720. [Google Scholar] [CrossRef] [PubMed]
  14. Cleusix, V.; Lacroix, C.; Vollenweider, S.; Duboux, M.; Le Blay, G. Inhibitory activity spectrum of reuterin produced by Lactobacillus reuteri against intestinal bacteria. BMC Microbiol. 2007, 7, 101. [Google Scholar] [CrossRef] [PubMed]
  15. Sun, M.-C.; Hu, Z.-Y.; Li, D.-D.; Chen, Y.-X.; Xi, J.-H.; Zhao, C.-H. Application of the Reuterin System as Food Preservative or Health-Promoting Agent: A Critical Review. Foods 2022, 11, 4000. [Google Scholar] [CrossRef] [PubMed]
  16. Zheng, J.; Wittouck, S.; Salvetti, E.; Franz, C.M.A.P.; Harris, H.M.B.; Mattarelli, P.; O’Toole, P.W.; Pot, B.; Vandamme, P.; Walter, J.; et al. A taxonomic note on the genus Lactobacillus: Description of 23 novel genera, emended description of the genus Lactobacillus Beijerinck 1901, and union of Lactobacillaceae and Leuconostocaceae. Int. J. Syst. Evol. Microbiol. 2020, 70, 2782–2858. [Google Scholar] [CrossRef] [PubMed]
  17. Engels, C.; Schwab, C.; Zhang, J.; Stevens, M.J.; Bieri, C.; Ebert, M.O.; McNeill, K.; Sturla, S.J.; Lacroix, C. Acrolein contributes strongly to antimicrobial and heterocyclic amine transformation activities of reuterin. Sci. Rep. 2016, 6, 36246. [Google Scholar] [CrossRef]
  18. Nasrollahzadeh, A.; Mokhtari, S.; Khomeiri, M.; Saris, P.E.J. Antifungal Preservation of Food by Lactic Acid Bacteria. Foods 2022, 11, 395. [Google Scholar] [CrossRef] [PubMed]
  19. Pawlowska, A.M.; Zannini, E.; Coffey, A.; Arendt, E.K. Chapter 5—“Green Preservatives”: Combating Fungi in the Food and Feed Industry by Applying Antifungal Lactic Acid Bacteria. In Advances in Food and Nutrition Research; Henry, J., Ed.; Academic Press: Cambridge, MA, USA, 2012; Volume 66, pp. 217–238. ISBN 9780123945976. ISSN 1043-4526. [Google Scholar] [CrossRef]
  20. Zhang, J.; Schwab, C. Is acrolein a reuterin-borne chemical hazard in biopreserved foods? Food Chem. Adv. 2022, 1, 100044. [Google Scholar] [CrossRef]
  21. Jiang, K.; Huang, C.; Liu, F.; Zheng, J.; Ou, J.; Zhao, D.; Ou, S. Origin and Fate of Acrolein in Foods. Foods 2022, 11, 1976. [Google Scholar] [CrossRef]
  22. Kächele, M.; Monakhova, Y.B.; Kuballa, T.; Lachenmeier, D.W. NMR investigation of acrolein stability in hydroalcoholic solution as a foundation for the valid HS-SPME/GC–MS quantification of the unsaturated aldehyde in beverages. Anal. Chim. Acta 2014, 820, 112–118. [Google Scholar] [CrossRef]
  23. Klein, M.; Swinnen, S.; Thevelein, J.M.; Nevoigt, E. Glycerol metabolism and transport in yeast and fungi: Established knowledge and ambiguities. Environ. Microbiol. 2017, 19, 878–893. [Google Scholar] [CrossRef] [PubMed]
  24. da Silva, G.P.; Mack, M.; Contiero, J. Glycerol: A promising and abundant carbon source for industrial microbiology. Biotechnol. Adv. 2009, 27, 30–39. [Google Scholar] [CrossRef] [PubMed]
  25. Matsakas, L.; Topakas, E.; Christakopoulos, P. New trends in microbial production of 3-hydroxypropionic acid. Curr. Biochem. Eng. 2014, 1, 141–154. [Google Scholar] [CrossRef]
  26. Luo, L.H.; Seo, J.-W.; Baek, J.-O.; Oh, B.-R.; Heo, S.-Y.; Hong, W.-K.; Kim, D.-H.; Kim, C.H. Identification and characterization of the propanediol utilization protein PduP of Lactobacillus reuteri for 3-hydroxypropionic acid production from glycerol. Appl. Microbiol. Biotechnol. 2011, 89, 697–703. [Google Scholar] [CrossRef] [PubMed]
  27. Bobik, T.A.; Havemann, G.D.; Busch, R.J.; Williams, D.S.; Aldrich, H.C. The propanediol utilization (pdu) operon of Salmonella enterica serovar Typhimurium LT2 includes genes necessary for formation of polyhedral organelles involved in coenzyme B(12)-dependent 1, 2-propanediol degradation. J. Bacteriol. 1999, 181, 5967–5975. [Google Scholar] [CrossRef]
  28. Morita, H.; Toh, H.; Fukuda, S.; Horikawa, H.; Oshima, K.; Suzuki, T.; Murakami, M.; Hisamatsu, S.; Kato, Y.; Takizawa, T.; et al. Comparative Genome Analysis of Lactobacillus reuteri and Lactobacillus fermentum Reveal a Genomic Island for Reuterin and Cobalamin Production. DNA Res. 2008, 15, 151–161. [Google Scholar] [CrossRef] [PubMed]
  29. Matsakas, L.; Hrůzová, K.; Rova, U.; Christakopoulos, P. Biological Production of 3-Hydroxypropionic Acid: An Update on the Current Status. Fermentation 2018, 4, 13. [Google Scholar] [CrossRef]
  30. Røssland, E.; Borge, G.I.A.; Langsrud, T.; Sørhaug, T. Inhibition of Bacillus cereus by strains of Lactobacillus and Lactococcus in milk. Int. J. Food Microbiol. 2004, 89, 205–212. [Google Scholar] [CrossRef]
  31. Arqués, J.L.; Fernández, J.; Gaya, P.; Nuñez, M.; Rodríguez, E.; Medina, M. Antimicrobial activity of reuterin in combination with nisin against foodborne pathogens. Int. J. Food Microbiol. 2004, 95, 225–229. [Google Scholar] [CrossRef]
  32. Tanaka, O.; Komatsu, T.; Oshibe, A.; Cai, Y.; Miyazaki, S.; Nakanishi, K. Production of 3-Hydroxypropionaldehyde in Silage Inoculated with Lactobacillus coryniformis Plus Glycerol. Biosci. Biotechnol. Biochem. 2009, 73, 1494–1499. [Google Scholar] [CrossRef]
  33. Tsuda, H. Production of reuterin by Lactobacillus coryniformis and its antimicrobial activities. J. Dairy Res. 2023, 90, 312–317. [Google Scholar] [CrossRef] [PubMed]
  34. Ortiz-Rivera, Y.; Sánchez-Vega, R.; Gutiérrez-Méndez, N.; León-Félix, J.; Acosta-Muñiz, C.; Sepulveda, D. Production of reuterin in a fermented milk product by Lactobacillus reuteri: Inhibition of pathogens, spoilage microorganisms, and lactic acid bacteria. J. Dairy Sci. 2017, 100, 4258–4268. [Google Scholar] [CrossRef] [PubMed]
  35. Vimont, A.; Fernandez, B.; Ahmed, G.; Fortin, H.-P.; Fliss, I. Quantitative antifungal activity of reuterin against food isolates of yeasts and moulds and its potential application in yogurt. Int. J. Food Microbiol. 2018, 289, 182–188. [Google Scholar] [CrossRef] [PubMed]
  36. Schaefer, L.; Auchtung, T.A.; Hermans, K.E.; Whitehead, D.; Borhan, B.; Britton, R.A. The antimicrobial compound reuterin (3-hydroxypropionaldehyde) induces oxidative stress via interaction with thiol groups. Microbiology 2010, 156 Pt 6, 1589–1599. [Google Scholar] [CrossRef] [PubMed]
  37. Purnawita, W.; Rahayu, W.P.; Lioe, H.N.; Nurjanah, S.; Wahyudi, S.T. Potential molecular mechanism of reuterin on the inhibition of Aspergillus flavus conidial germination: An in silico study. J. Food Sci. 2024, 89, 1167–1186. [Google Scholar] [CrossRef] [PubMed]
  38. Pilote-Fortin, H.; Said, L.B.; Cashman-Kadri, S.; St-Gelais, D.; Fliss, I. Stability, bioavailability and antifungal activity of reuterin during manufacturing and storage of stirred yoghurt. Int. Dairy J. 2021, 121, 105141. [Google Scholar] [CrossRef]
  39. Liu, A.; Xu, R.; Zhang, S.; Wang, Y.; Hu, B.; Ao, X.; Li, Q.; Li, J.; Hu, K.; Yang, Y.; et al. Antifungal Mechanisms and Application of Lactic Acid Bacteria in Bakery Products: A Review. Front. Microbiol. 2022, 13, 924398. [Google Scholar] [CrossRef]
  40. Gerez, C.L.; Torino, M.I.; Rollán, G.; de Valdez, G.F. Prevention of bread mould spoilage by using lactic acid bacteria with antifungal properties. Food Control 2009, 20, 144–148. [Google Scholar] [CrossRef]
  41. Debonne, E.; Vermeulen, A.; Bouboutiefski, N.; Ruyssen, T.; Van Bockstaele, F.; Eeckhout, M.; Devlieghere, F. Modelling and validation of the antifungal activity of DL-3-phenyllactic acid and acetic acid on bread spoilage moulds. Food Microbiol. 2020, 88, 103407. [Google Scholar] [CrossRef]
  42. Meruvu, H. Redefining methods for augmenting lactic acid bacteria robustness and phenyllactic acid biocatalysis: Integration valorizes simplicity. Crit. Rev. Food Sci. Nutr. 2022, 1–13. [Google Scholar] [CrossRef]
  43. Dieuleveux, V.; Lemarinier, S.; Guéguen, M. Antimicrobial spectrum and target site of d-3-phenyllactic acid. Int. J. Food Microbiol. 1998, 40, 177–183. [Google Scholar] [CrossRef] [PubMed]
  44. Lee, W.; Park, Y.-T.; Lim, S.; Yeom, S.H.; Jeon, C.; Lee, H.-S.; Yeon, Y.J. Efficient Production of Phenyllactic Acid by Whole-cell Biocatalysis with Cofactor Regeneration System. Biotechnol. Bioprocess Eng. 2021, 26, 402–407. [Google Scholar] [CrossRef]
  45. Jung, S.; Hwang, H.; Lee, J.-H. Effect of lactic acid bacteria on phenyllactic acid production in kimchi. Food Control 2019, 106, 106701. [Google Scholar] [CrossRef]
  46. Luo, X.; Zhang, Y.; Yin, L.; Zheng, W.; Fu, Y. Efficient synthesis of d-phenyllactic acid by a whole-cell biocatalyst co-expressing glucose dehydrogenase and a novel d-lactate dehydrogenase from Lactobacillus rossiae. 3 Biotech 2020, 10, 14. [Google Scholar] [CrossRef] [PubMed]
  47. Schwenninger, S.M.; Lacroix, C.; Truttmann, S.; Jans, C.; Spörndli, C.; Bigler, L.; Meile, L. Characterization of low-molecular-weight antiyeast metabolites produced by a food-protective Lactobacillus-Propionibacterium coculture. Food Prot. 2008, 71, 2481–2487. [Google Scholar] [CrossRef] [PubMed]
  48. Ryan LA, M.; Bello, F.D.; Czerny, M.; Koehler, P.; Arendt, E.K. Quantification of phenyllactic acid in wheat sourdough using high resolution gas chromatography− mass spectrometry. J. Agric. Food Chem. 2009, 57, 1060–1064. [Google Scholar] [CrossRef]
  49. Rajanikar, R.; Nataraj, B.H.; Naithani, H.; Ali, S.A.; Panjagari, N.R.; Behare, P.V. Phenyllactic acid: A green compound for food biopreservation. Food Control 2021, 128, 108184. [Google Scholar] [CrossRef]
  50. Lavermicocca, P.; Valerio, F.; Visconti, A. Antifungal activity of phenyllactic acid against molds isolated from bakery products. Appl. Environ. Microbiol. 2003, 69, 634–640. [Google Scholar] [CrossRef]
  51. Ryan, L.A.M.; Zannini, E.; Dal Bello, F.; Pawlowska, A.; Koehler, P.; Arendt, E.K. Lactobacillus amylovorus DSM 19280 as a novel food-grade antifungal agent for bakery products. Int. J. Food Microbiol. 2011, 146, 276–283. [Google Scholar] [CrossRef]
  52. Lipinska-Zubrycka, L.; Klewicki, R.; Sojka, M.; Bonikowski, R.; Milczarek, A.; Klewicka, E. Anticandidal activity of Lactobacillus spp. in the presence of galactosyl polyols. Microbiol. Res. 2020, 240, 126540. [Google Scholar] [CrossRef]
  53. Wu, W.; Deng, G.; Liu, C.; Gong, X.; Ma, G.; Yuan, Q.; Yang, E.; Li, X.-R.; Luo, Y.-Y. Optimization and Multiomic Basis of Phenyllactic Acid Overproduction by Lactobacillus plantarum. J. Agric. Food Chem. 2020, 68, 1741–1749. [Google Scholar] [CrossRef] [PubMed]
  54. Gerez, C.; Carbajo, M.; Rollán, G.; Leal, G.T.; de Valdez, G.F. Inhibition of Citrus Fungal Pathogens by Using Lactic Acid Bacteria. J. Food Sci. 2010, 75, M354–M359. [Google Scholar] [CrossRef] [PubMed]
  55. Russo, P.; Arena, M.P.; Fiocco, D.; Capozzi, V.; Drider, D.; Spano, G. Lactobacillus plantarum with broad antifungal activity: A promising approach to increase safety and shelf-life of cereal-based products. Int. J. Food Microbiol. 2017, 247, 48–54. [Google Scholar] [CrossRef]
  56. Quattrini, M.; Liang, N.; Fortina, M.G.; Xiang, S.; Curtis, J.M.; Gänzle, M. Exploiting synergies of sourdough and antifungal organic acids to delay fungal spoilage of bread. Int. J. Food Microbiol. 2019, 302, 8–14. [Google Scholar] [CrossRef] [PubMed]
  57. Valerio, F.; Di Biase, M.; Lattanzio, V.M.; Lavermicocca, P. Improvement of the antifungal activity of lactic acid bacteria by addition to the growth medium of phenylpyruvic acid, a precursor of phenyllactic acid. Int. J. Food Microbiol. 2016, 222, 1–7. [Google Scholar] [CrossRef]
  58. Pradhan, D.; Kadyan, S. Antifungal Lactic Acid Bacteria (LAB): Potential Use in Food Systems; Taylor & Francis Ltd.: London, UK, 2020. [Google Scholar]
  59. Dopazo, V.; Illueca, F.; Luz, C.; Musto, L.; Moreno, A.; Calpe, J.; Meca, G. Evaluation of shelf life and technological properties of bread elaborated with lactic acid bacteria fermented whey as a bio-preservation ingredient. LWT 2023, 174, 114427. [Google Scholar] [CrossRef]
  60. Kavitake, D.; Tiwari, S.; Shah, I.A.; Devi, P.B.; Delattre, C.; Reddy, G.B.; Shetty, P.H. Antipathogenic potentials of exopolysaccharides produced by lactic acid bacteria and their food and health applications. Food Control 2023, 152, 109850. [Google Scholar] [CrossRef]
  61. Sutherland, I. Phage-induced fucosidases hydrolysing the exopolysaccharide of Klebsiella arogenes type 54 [A3(S1)]. Biochem. J. 1967, 104, 278–285. [Google Scholar] [CrossRef]
  62. Sanalibaba, P.; Cakmak, G.A. Exopolysaccharides Production by Lactic Acid Bacteria. Appl. Microbiol. Open Access 2016, 2, 1000115. [Google Scholar] [CrossRef]
  63. Mozzi, F.; Vaningelgem, F.; Hébert, E.M.; Van der Meulen, R.; Moreno, M.R.F.; de Valdez, G.F.; De Vuyst, L. Diversity of heteropolysaccharide-producing lactic acid bacterium strains and their biopolymers. Appl. Environ. Microbiol. 2006, 72, 4431–4435. [Google Scholar] [CrossRef]
  64. Werning, M.L.; Hernández-Alcántara, A.M.; Ruiz, M.J.; Soto, L.P.; Dueñas, M.T.; López, P.; Frizzo, L.S. Biological Functions of Exopolysaccharides from Lactic Acid Bacteria and Their Potential Benefits for Humans and Farmed Animals. Foods 2022, 11, 1284. [Google Scholar] [CrossRef]
  65. Nicolescu, C.M.; Bumbac, M.; Buruleanu, C.L.; Popescu, E.C.; Stanescu, S.G.; Georgescu, A.A.; Toma, S.M. Biopolymers Produced by Lactic Acid Bacteria: Characterization and Food Application. Polymers 2023, 15, 1539. [Google Scholar] [CrossRef] [PubMed]
  66. Dey, G.; Patil, M.P.; Banerjee, A.; Sharma, R.K.; Banerjee, P.; Maity, J.P.; Singha, S.; Taharia, M.; Shaw, A.K.; Huang, H.-B.; et al. The role of bacterial exopolysaccharides (EPS) in the synthesis of antimicrobial silver nanomaterials: A state-of-the-art review. J. Microbiol. Methods 2023, 212, 106809. [Google Scholar] [CrossRef] [PubMed]
  67. Cerning, J. Exocellular polysaccharides produced by lactic acid bacteria. FEMS Microbiol. Lett. 1990, 87, 113–130. [Google Scholar] [CrossRef]
  68. De Vuyst, L.; Degeest, B. Heteropolysaccharides from lactic acid bacteria. FEMS Microbiol. Rev. 1999, 23, 153–177. [Google Scholar] [CrossRef]
  69. Hakim, B.N.A.; Xuan, N.J.; Oslan, S.N.H. A Comprehensive Review of Bioactive Compounds from Lactic Acid Bacteria: Potential Functions as Functional Food in Dietetics and the Food Industry. Foods 2023, 12, 2850. [Google Scholar] [CrossRef] [PubMed]
  70. Nabot, M.; Guérin, M.; Sivakumar, D.; Remize, F.; Garcia, C. Variability of Bacterial Homopolysaccharide Production and Properties during Food Processing. Biology 2022, 11, 171. [Google Scholar] [CrossRef]
  71. Daba, G.M.; Elnahas, M.O.; Elkhateeb, W.A. Contributions of exopolysaccharides from lactic acid bacteria as biotechnological tools in food, pharmaceutical, and medical applications. Int. J. Biol. Macromol. 2021, 173, 79–89. [Google Scholar] [CrossRef]
  72. Miyamoto, J.; Shimizu, H.; Hisa, K.; Matsuzaki, C.; Inuki, S.; Ando, Y.; Nishida, A.; Izumi, A.; Yamano, M.; Ushiroda, C.; et al. Host metabolic benefits of prebiotic exopolysaccharides produced by Leuconostoc mesenteroides. Gut Microbes 2023, 15, 2161271. [Google Scholar] [CrossRef]
  73. Sørensen, H.M.; Rochfort, K.D.; Maye, S.; MacLeod, G.; Brabazon, D.; Loscher, C.; Freeland, B. Exopolysaccharides of Lactic Acid Bacteria: Production, Purification and Health Benefits towards Functional Food. Nutrients 2022, 14, 2938. [Google Scholar] [CrossRef]
  74. Malang, S.K.; Maina, N.H.; Schwab, C.; Tenkanen, M.; Lacroix, C. Characterization of exopolysaccharide and ropy capsular polysaccharide formation by Weissella. Food Microbiol. 2015, 46, 418–427. [Google Scholar] [CrossRef] [PubMed]
  75. Liu, H.; Yan, H.; Xiao, Y.; Nie, H.; Huang, Q.; Chen, W. The exopolysaccharide gene cluster pea is transcriptionally controlled by RpoS and repressed by AmrZ in Pseudomonas putida KT2440. Microbiol. Res. 2019, 218, 1–11. [Google Scholar] [CrossRef] [PubMed]
  76. Zhang, J.; Xiao, Y.; Wang, H.; Zhang, H.; Chen, W.; Lu, W. Lactic acid bacteria-derived exopolysaccharide: Formation, immunomodulatory ability, health effects, and structure-function relationship. Microbiol. Res. 2023, 274, 127432. [Google Scholar] [CrossRef] [PubMed]
  77. Boels, I.C.; van Kranenburg, R.; Hugenholtz, J.; Kleerebezem, M.; de Vos, W.M. Sugar catabolism and its impact on the biosynthesis and engineering of exopolysaccharide production in lactic acid bacteria. Int. Dairy J. 2001, 11, 723–732. [Google Scholar] [CrossRef]
  78. Whitney, J.; Howell, P. Synthase-dependent exopolysaccharide secretion in Gram-negative bacteria. Trends Microbiol. 2013, 21, 63–72. [Google Scholar] [CrossRef] [PubMed]
  79. Abinaya, M.; Vaseeharan, B.; Divya, M.; Sharmili, A.; Govindarajan, M.; Alharbi, N.S.; Kadaikunnan, S.; Khaled, J.M.; Benelli, G. Bacterial exopolysaccharide (EPS)-coated ZnO nanoparticles showed high antibiofilm activity and larvicidal toxicity against malaria and Zika virus vectors. J. Trace Elem. Med. Biol. 2018, 45, 93–103. [Google Scholar] [CrossRef]
  80. Han, G.; Liang, C.-Z.; Chung, T.-S.; Weber, M.; Staudt, C.; Maletzko, C. Combination of forward osmosis (FO) process with coagulation/flocculation (CF) for potential treatment of textile wastewater. Water Res. 2016, 91, 361–370. [Google Scholar] [CrossRef]
  81. Wang, J.; Zhao, X.; Yang, Y.; Zhao, A.; Yang, Z. Characterization and bioactivities of an exopolysaccharide produced by Lactobacillus plantarum YW32. Int. J. Biol. Macromol. 2015, 74, 119–126. [Google Scholar] [CrossRef]
  82. Wang, K.; Niu, M.; Song, D.; Song, X.; Zhao, J.; Wu, Y.; Liu, B.; Niu, J. Preparation, partial characterization and biological activity of exopolysaccharides produced from Lactobacillus fermentum S1. J. Biosci. Bioeng. 2020, 129, 206–214. [Google Scholar] [CrossRef]
  83. Allonsius, C.N.; van den Broek MF, L.; De Boeck, I.; Kiekens, S.; Oerlemans EF, M.; Kiekens, F.; Foubert, K.; Vandenheuvel, D.; Cos, P.; Delputte, P.; et al. Interaction between Lactobacillus rhamnosus GG and Candida and involvement of exopolysaccharides. Microb. Biotechnol. 2017, 10, 1753–1763. [Google Scholar] [CrossRef]
  84. Abouloifa, H.; Rokni, Y.; Bellaouchi, R.; Ghabbour, N.; Karboune, S.; Brasca, M.; Ben Salah, R.; Chihib, N.E.; Saalaoui, E.; Asehraou, A. Characterisation of probiotic properties of antifungal Lactobacillus strains isolated from traditionally fermented green olives. Probiotics Antimicrob. Proteins 2020, 12, 683–696. [Google Scholar] [CrossRef]
  85. Mailänder-Sánchez, D.; Braunsdorf, C.; Grumaz, C.; Müller, C.; Lorenz, S.; Stevens, P.; Wagener, J.; Hebecker, B.; Hube, B.; Bracher, F.; et al. The antifungal defence of the probiotic Lactobacillus rhamnosus GG is mediated by adhesion blockade and nutrient depletion. PLoS ONE 2017, 12, e0184438. [Google Scholar] [CrossRef]
  86. El-Mahdy, O.M.; Mohamed, H.I.; El-Ansary, A.E. Optimisations of exopolysaccharide production by Fusarium nygamai strain AJTYC1 and its potential applications as an antioxidant, antimicrobial, anticancer, and emulsifier. BMC Microbiol. 2023, 23, 345. [Google Scholar] [CrossRef]
  87. Illueca, F.; Moreno, A.; Calpe, J.; Nazareth, T.d.M.; Dopazo, V.; Meca, G.; Quiles, J.M.; Luz, C. Bread Biopreservation through the Addition of Lactic Acid Bacteria in Sourdough. Foods 2023, 12, 864. [Google Scholar] [CrossRef]
Figure 4. Classification of exopolysaccharides of bacterial origin.
Figure 4. Classification of exopolysaccharides of bacterial origin.
Foods 13 00752 g004
Figure 5. The extracellular and the synthase-dependent pathway of HoPSs.
Figure 5. The extracellular and the synthase-dependent pathway of HoPSs.
Foods 13 00752 g005
Figure 6. The Wzx/Wzy-dependent pathway of HePSs. A: β-Galactosidase and Glucokinase; B: Galactose mutarotase; C: α-Phosphoglucomutase; D: Glucose-6-phosphate isomerase; E: 1-phosphofructokinase; F: Phosphomannomutase and Mannose 1-phosphateguanylystransferase; G: Glucosamine-6-phosphate deaminase; H: Mannose-6-phosphate isomerase; I: α-Galactokinase; J: Glucose-1-phosphate thymidylyltransferase; K: Phosphomannomutase; L: Phosphoglucosamine mutase; M: UDP-N-acetylglucosamine pyrophosphorylase; N: Mannose 1-phosphateguanylystransferase; O: dTDP-glucose 4,6-dehydratase; P: UTP-glucose-1-phosphate uridylyltransferase; Q: UDP-glucose–hexose-1-phosphate uridylyltransferase; R: UDP-glucose 4-epimerase; S: dTDP-4-dehydrorhamnose 3,5-epimerase; T: GDP-mannose-4,6-dehydratase; U: UDP-glucose 4-epimerase; V: dTDP-4-dehydrorhamnose reductase.
Figure 6. The Wzx/Wzy-dependent pathway of HePSs. A: β-Galactosidase and Glucokinase; B: Galactose mutarotase; C: α-Phosphoglucomutase; D: Glucose-6-phosphate isomerase; E: 1-phosphofructokinase; F: Phosphomannomutase and Mannose 1-phosphateguanylystransferase; G: Glucosamine-6-phosphate deaminase; H: Mannose-6-phosphate isomerase; I: α-Galactokinase; J: Glucose-1-phosphate thymidylyltransferase; K: Phosphomannomutase; L: Phosphoglucosamine mutase; M: UDP-N-acetylglucosamine pyrophosphorylase; N: Mannose 1-phosphateguanylystransferase; O: dTDP-glucose 4,6-dehydratase; P: UTP-glucose-1-phosphate uridylyltransferase; Q: UDP-glucose–hexose-1-phosphate uridylyltransferase; R: UDP-glucose 4-epimerase; S: dTDP-4-dehydrorhamnose 3,5-epimerase; T: GDP-mannose-4,6-dehydratase; U: UDP-glucose 4-epimerase; V: dTDP-4-dehydrorhamnose reductase.
Foods 13 00752 g006
Figure 7. Overview of properties requiring further investigation.
Figure 7. Overview of properties requiring further investigation.
Foods 13 00752 g007
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Ponzio, A.; Rebecchi, A.; Zivoli, R.; Morelli, L. Reuterin, Phenyllactic Acid, and Exopolysaccharides as Main Antifungal Molecules Produced by Lactic Acid Bacteria: A Scoping Review. Foods 2024, 13, 752. https://doi.org/10.3390/foods13050752

AMA Style

Ponzio A, Rebecchi A, Zivoli R, Morelli L. Reuterin, Phenyllactic Acid, and Exopolysaccharides as Main Antifungal Molecules Produced by Lactic Acid Bacteria: A Scoping Review. Foods. 2024; 13(5):752. https://doi.org/10.3390/foods13050752

Chicago/Turabian Style

Ponzio, Andrea, Annalisa Rebecchi, Rosanna Zivoli, and Lorenzo Morelli. 2024. "Reuterin, Phenyllactic Acid, and Exopolysaccharides as Main Antifungal Molecules Produced by Lactic Acid Bacteria: A Scoping Review" Foods 13, no. 5: 752. https://doi.org/10.3390/foods13050752

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop